Kristin Gerber is a partner in the firm's Business Law department and a member of its nationally recognized Technology and Life Sciences group, including its market leading Technology M&A practice. Kristin represents domestic and non-US public and private acquirers, investors, and companies in mergers and acquisitions, dispositions, and corporate finance transactions focusing on software, hardware, biotechnology, pharmaceuticals and other technology-driven industries. Serving as her corporate clients’ general or principal outside counsel, Kristin provides strategic advice and general corporate counseling to management teams and boards while leading significant transactions on her clients’ behalf through every stage of the corporate life cycle. Kristin is heavily involved in the emerging technology and life science startup communities in Boston, regularly advising and mentoring young companies and entrepreneurs.
Kristin is a key contributor to Goodwin’s ESG & Impact practice and devotes a portion of her practice to counseling social enterprise companies, impact investors, and nonprofit companies with respect to complex corporate structures, governance and sustainability, impact metrics, financings and grant development, strategic alliances, and commercial contracts.
Representative Matters
- Represented Klaviyo, Inc. in initial public offering
- Represented Memorable AI in sale to Reddit
- Represented Akston Bio in asset sale to Dechra
- Represented Ultimate.ai in sale to Zendesk
- Represented Klaviyo in acquisition of Napkin.io
- Represented Finmark in sale to Bill.com
- Represented Apollo Intelligence in sale to Frazier Healthcare Partners
- Represented Lucid Holdings in $1.1B sale to Cint Group AB
- Represented Checkr in acquisition of GoodHire
- Represented Wellframe in sale to HealthEdge Software
- Represented Compass Therapeutics in acquisition of TRIGR Therapeutics
- Represented Salsify in acquisition of Alkemics
- Represented Pitango Venture Capital, Evergreen Venture Partners and Fidelity Management & Research Company LLC in the acquisition of Taboola by Ion Acquisition Corp. 1 Ltd.
- Represented Bessemer Venture Partners in the acquisition of Otonomo Technologies by Software Acquisition Group Inc. II
- Represented TriNetX in sale of majority stake to The Carlyle Group
- Represented Stella Connect in sale to Medallia
- Represented Checkmate Pharmaceuticals, Inc. in initial public offering
- Represented Apollo Intelligence in acquisition of SHG Global
- Represented private equity company in $42 million acquisition of market research company
- Represented Mobeewave in $115 million stock sale to Apple
- Represented InCrowd in sale to Saroras
- Represented Iconics in sale to Mitsubishi Electric
- Represented Flywheel in sale to WP Engine
- Represented StellaService in asset sale to PowerReviews and $11 million Series B financing by Harbert Growth Partners and Zendesk
- Represented Kyn Therapeutics in stock-for-stock acquisition of Arrys Therapeutics
- Represented Qualtrics in $8 billion sale to SAP
- Represented biotech in $750 million sale to public pharmaceutical company*
- Represented biotech in $400 million sale to foreign pharmaceutical company*
- Represented public energy company in $220 million acquisition of foreign energy company*
* Denotes experience prior to joining Goodwin.
- Represented Spear Bio in $45 million Series A financing led by Foresite and Bio-Techne
- Represented Piva Capital in Series C financing of Oobli
- Represented Material Evolution in itsSeries B financing led by KOMPAS Ventures and Norrsken
- Represented VMG Partners in Series B financing of Rinsed
- Represented AptiHealth in itsSeries B financing led by Takeda Digital Ventures
- Represented Surface Ventures as lead investor in Salesbricks Series Seed financing
- Represented Klaviyo in strategic partnership and financing with Shopify
- Represented WiTricity in Series B financing led by Siemens and existing investors
- Represented Mantra Health in $22 million Series A financing led by VMG Partners
- Represented consortium led by Novastar, FMO and Global Ventures in Series B financing of TeamApt
- Represented Klaviyo in $320 million Series D financing by consortium led by Sands Capital
- Represented Stavvy in $40 million Series A financing by Morningside Technology Ventures
- Represented MBX Biosciences in $34.6 million Series A financing by Frasier, OrbiMed and NEA
- Represented Komaza, Inc. in $28 million Series B financing led by AXA, FMO and Novastar
- Represented Checkmate Pharmaceuticals in $85 million Series C financing by consortium led by Longitude and Novo
- Represented Novastar Ventures as lead investor in $21.5 million Series C financing of mPharma Data
- Represented Checkmate Pharmaceuticals in $90 million Series B financing by Sofinnova, venBio, F-Prime and Decheng Capital
- Represented biotech issuer in $300 million convertible limited recourse “synthetic” note financing, $200 million Series DD financing and $75 million equipment finance facility*
* Denotes experience prior to joining Goodwin.
Professional Activities
Kristin is a member of the American and Boston Bar Associations, the Global Impact Investing Network, the Impact Investing Legal Working Group, and the Boston chapter of Women in Technology International. She has also served as a mentor for the MIT $100K Business Plan Competition, Cleantech Open Northeast, Boston College’s Soaring Startup Circle, and the Hult Prize Competition, and has been a guest lecturer at Boston College Law School.
Professional Experience
Prior to joining Goodwin, Kristin practiced as an associate at prominent Boston-based international law firms. She has also served as a judicial intern to the Honorable Chief Judge Joseph Bataillon in the United States District Court for the District of Nebraska and worked as a corporate auditor for the Union Pacific Corporation.
Credentials
Education
JD2008
Boston College Law School
BSBA2003
Creighton University
Admissions
Bars
- Massachusetts
Recognition & Awards
Kristin has been recognized in The Best Lawyers in America for Mergers and Acquisitions Law, Healthcare Law and Venture Capital Law (2023) and as a Massachusetts Super Lawyer "Rising Star" by Law & Politics and Boston magazine (2015, 2016, 2017, 2018, 2019, 2020).
Publications
Co-author, “Regulation Crowdfunding: The Long Wait Is Over, But Is Equity Crowdfunding D.O.A.?,” Venture Capital & Emerging Companies Alert, 2015
Co-author, “Takeover Considerations and Defenses,” Financing a Business in Massachusetts, MCLE, Inc., 2010